Filter
1197
Text search:
human
pharmaceutical
products
Featured
113
332
Language
Document type
603
242
179
67
64
15
13
8
4
1
1
Countries / Regions
60
44
42
37
27
26
26
24
23
23
22
19
18
18
17
17
15
14
13
12
12
11
11
11
11
9
9
8
7
6
6
6
6
6
5
5
4
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
494
90
60
41
31
24
8
1
Toolboxes
157
129
72
57
49
47
41
39
25
22
21
20
19
16
14
9
7
6
5
5
3
1
Towards a Healthier Botswana
The essential medicines are those that meet the priority needs of the healthcare of the population. While reviewing the 5th edition of the essential Medicines, special attention focused on the health sector policy. Indeed, medicines play an important role in protecting, maintaining and restoring th
...
Second Generation, WHO Country Cooperation Strategy, 2010–2015, Namibia
Antimicrobial resistance (AMR) is a multifaceted, international public health problem, which poses a direct threat to the safety of the population of South Africa. A national response is required to complement the development of a global plan, as articulated in the WHO’s draft resolution EB134/37
...
Accessed November, 2017
DRUGS REGULATORY UNIT | NOVEMBER 2009 | SECOND EDITION
Accessed November 2017
Therapeutics Information and Pharmacovigilance Centre | TIPC
Lessons from the STEP-TB Project.
Accessed November 2017.
Framework for implementation.
The END TB Strategy.
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo
...
Experience of national TB partnerships
